Oedema drug may benefit children with ASD: study
It's worth considering but under close medical supervision, US expert says
6th February 2020
Three months of treatment with a bumetanide, a drug used to treat oedema, improves autism spectrum disorder (ASD) symptoms in children aged 3-6, a clinical trial suggests.